missing translation for 'onlineSavingsMsg'
Learn More
Learn More
DiscoverX PathHunter™ U2OS LCK Activity Assay
Description
The PathHunter™ U2OS LCK Activity Assay is a stable, engineered cell line for use in studying small molecule drug candidates targeting CTKs. This cell line enables assessment of CTK activation via detection of resulting GHR phosphorylation-induced SH2 domain protein recruitment, mediated by LCK-JAK2 fusion protein. This product uses EFC technology. The included cell line overexpresses PK-tagged relevant cytokine receptor and EA-tagged SH2 domain protein alongside an engineered fusion of the cytokine receptor binding domain of JAK2 (Janus Kinase 2) to the catalytic domain from the CTK of interest, LCK. Upon activation of the cytokine receptor, the CRBD-CTK fusion phosphorylates the receptor, leading to SH2-EA recruitment and production of EFC signal. This stable modified cell line is provided as two vials of cryopreserved cells.
Specifications
Specifications
| Assay Entry | SH2 Recruitment |
| Cell Line | U2OS |
| For Use With (Application) | Cell Lines |
| Primary Agonist | Recombinant Human Growth Hormone |
| Quantity | 2 Vials |
| Target Entry | LCK |
| Accession Number | NM_000163 |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?